Fischer Medical Ventures Limited has scheduled a meeting of the Board of Directors to be held on Friday, May 29, 2026, through video conferencing. The meeting is being convened pursuant to Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
The agenda for the board meeting includes:
- Consideration and taking on record the audited standalone and consolidated financial results of the company for the quarter and year ended March 31, 2026
- Recommendation of dividend, if any
- Transaction of any other matter as may be specified in the agenda
The company also confirmed that the trading window for dealing in the equity shares of the Company is already closed for all designated persons, their immediate relatives, and other connected persons. This closure was previously communicated via letter dated March 30, 2026. The trading window will remain closed until the conclusion of 48 hours after the declaration of financial results for the quarter and year ended March 31, 2026.
The disclosure was signed by Balaji Gandla, Company Secretary & Compliance Officer, and addressed to both BSE Limited and National Stock Exchange of India Ltd.